Pluristem Therapeutics Inc (PSTI)

[zzaatt]

I think you're quite right: either the Tnuva agreement or the clinical study could give us a VERY substantial PPS boost.

"Cautious optimism" is a reasonable stance (as with any small pre-product biotech), but my sense is (and has been) that Pluristem is smack in the middle of one of the most important avant-guard areas of medical advance, and the likelihood of monetizing their accumulated technical know-how and patent base is reasonably high.